SXI Life Sciences
7.550,41
PKT
+25,00
PKT
+0,33
%
Werbung
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 21.04.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 21.04.21 | Roche Outperform | Bernstein Research | |
| 19.04.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 09.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 07.04.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 07.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 24.03.21 | Roche overweight | Barclays Capital | |
| 24.03.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 24.03.21 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 23.03.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 23.03.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 23.03.21 | Novartis buy | Jefferies & Company Inc. | |
| 23.03.21 | Novartis market-perform | Bernstein Research | |
| 23.03.21 | Roche Outperform | Bernstein Research | |
| 23.03.21 | Roche Neutral | UBS AG | |
| 23.03.21 | Roche Hold | Deutsche Bank AG | |
| 23.03.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.03.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 22.03.21 | Roche overweight | Barclays Capital | |
| 22.03.21 | Novartis market-perform | Bernstein Research | |
| 22.03.21 | Roche Neutral | UBS AG | |
| 22.03.21 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 22.03.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 16.03.21 | Roche Hold | Jefferies & Company Inc. | |
| 15.03.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.03.21 | Roche Neutral | UBS AG | |
| 10.03.21 | Novartis buy | Deutsche Bank AG | |
| 09.03.21 | Roche buy | Citigroup Corp. | |
| 09.03.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 09.03.21 | Novartis buy | Jefferies & Company Inc. | |
| 08.03.21 | Roche Neutral | UBS AG | |
| 24.02.21 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.02.21 | Novartis buy | UBS AG | |
| 18.02.21 | Novartis buy | Deutsche Bank AG | |
| 17.02.21 | Roche Neutral | UBS AG | |
| 16.02.21 | Novartis buy | Deutsche Bank AG | |
| 15.02.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 15.02.21 | Roche Hold | Deutsche Bank AG | |
| 12.02.21 | Roche Outperform | Bernstein Research | |
| 11.02.21 | Roche Conviction Buy | Goldman Sachs Group Inc. |